Watanabe Todd Insider Trading Activity

Corporate InsiderSee Remarks · CIK 1801061

15

Total trades

$5.6M

Total volume

May 4, 2026

Last activity

ARQT

Arcutis Biotherapeutics, Inc.

Watanabe Todd has been net-selling over the last 12 months with 0 purchases and 15 sales across 1 company.

ARQT is the most-traded position with 15 trades. The largest single transaction was a sale of ARQT for $1.5M on Nov 24, 2025.

Performance Scorecard

Forward stock performance after each transaction by Watanabe Todd. Buy returns measure price movement after open-market purchases; sell-avoided measures the loss avoided after open-market sales. Success rate counts trades where the insider's direction was right.

PERIODAVG BUY RETURNAVG SELL AVOIDEDSUCCESS RATETRADES
30 days-11.1%40%15
90 days-22.1%36%14
120 days-18.8%36%14

Performance based on stock price movement after each transaction date. Past results do not predict future returns. Not financial advice.

Price & Trades

Pro: Trade Markers

ARQT · Arcutis Biotherapeutics, Inc.

🔒 Subscribe to see trade entries

Pro members see exactly when Watanabe Todd bought and sold ARQT.

Upgrade to Pro

Recent Trades

DATETICKERTYPESHARESPRICEVALUEΔ OWNEDROLEFILING
May 4, 2026
ARQTSell3,172$23.61$75K−0.4%See Remarks
Mar 2, 2026
ARQTSell36,281$25.16$913K−4.4%See Remarks
Mar 2, 2026
ARQTSell1,068$25.91$28K−0.1%See Remarks
Feb 2, 2026
ARQTSell19,833$25.50$506K−2.7%See Remarks
Nov 24, 2025
ARQTSell48,945$30.36$1.5M−6.2%See Remarks
Nov 21, 2025
ARQTSell1,055$30.00$32K−0.1%See Remarks
Nov 3, 2025
ARQTSell69$25.40$2K−0.0%See Remarks
Nov 3, 2025
ARQTSell11,478$24.71$284K−1.4%See Remarks
Oct 28, 2025
ARQTSell40,000$25.03$1.0M−4.7%See Remarks
Oct 2, 2025
ARQTSell20,739$20.04$416K−2.4%See Remarks
Oct 1, 2025
ARQTSell9,261$20.02$185K−1.1%See Remarks
Oct 1, 2025
ARQTSell15,000$18.91$284K−1.7%See Remarks
Sep 9, 2025
ARQTSell504$17.52$9K−0.1%See Remarks
Sep 8, 2025
ARQTSell9,625$17.54$169K−1.1%See Remarks
Aug 4, 2025
ARQTSell11,547$14.33$165K−1.3%See Remarks

Top Companies Traded

TICKERCOMPANYTRADESTOTAL VOLUME
ARQTArcutis Biotherapeutics, Inc.15$5.6M

Other insiders at Arcutis Biotherapeutics, Inc.

6 other tracked filers at ARQT.